---
title: "000661.SZ (000661.SZ) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/000661.SZ/news.md"
symbol: "000661.SZ"
name: "000661.SZ"
parent: "https://longbridge.com/zh-HK/quote/000661.SZ.md"
datetime: "2026-03-17T04:53:53.021Z"
locales:
  - [en](https://longbridge.com/en/quote/000661.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000661.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000661.SZ/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/000661.SZ/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/000661.SZ/news.md)


# 000661.SZ (000661.SZ) — 相關新聞

### [GenSci Pharmaceutical's new cancer drug GenSci128 has received FDA orphan drug designation](https://longbridge.com/zh-HK/news/278677930.md)
*2026-03-11T07:48:08.000Z*
> Changchun JinSai Pharmaceutical's GenSci128 tablets have received FDA orphan drug designation for the treatment of pancr

### [US FDA Grants Orphan Drug Designation to Changchun High-Tech Industry Unit's GenSci128 Tablets](https://longbridge.com/zh-HK/news/278654649.md)
*2026-03-11T04:05:35.000Z*
> US FDA Grants Orphan Drug Designation to Changchun High-Tech Industry Unit's GenSci128 Tablets

### [CCHT subsidiary GenSci128 has received orphan drug designation from the U.S. FDA](https://longbridge.com/zh-HK/news/278538403.md)
*2026-03-10T10:43:02.000Z*
> CCHT's subsidiary Jinsai Pharmaceutical recently received orphan drug designation from the U.S. FDA for GenSci128, which

### [GenSci128 Receives Orphan Drug Designation for Pancreatic Cancer Treatment](https://longbridge.com/zh-HK/news/278534545.md)
*2026-03-10T10:12:42.000Z*
> Changchun High-Tech's subsidiary, Changchun GeneScience Pharmaceuticals, has received orphan drug designation from the U

### [Changchun High-Tech Industry Files Clinical Trial Application for GenSci161 Injection](https://longbridge.com/zh-HK/news/277574518.md)
*2026-03-03T06:56:48.000Z*
> Changchun High-Tech Industry Files Clinical Trial Application for GenSci161 Injection

### [CCHT: The clinical trial application for the domestic production drug registration of GenSci161 injection has been accepted](https://longbridge.com/zh-HK/news/277430970.md)
*2026-03-02T08:42:02.000Z*
> The domestic production drug registration clinical trial application for GenSci161 injection from Changchun High-tech's 

### [Is "Yin Weida," which ignited the stock price of CCHT, really that amazing?](https://longbridge.com/zh-HK/news/277220587.md)
*2026-02-27T15:04:10.000Z*
> CCHT has attracted attention due to the approval of clinical trials for its drug GenSci141 ointment, which targets the i

### [Despite a performance disaster, Changchun High-tech's stock price surged, transforming into "Yin Weida" for a comeback](https://longbridge.com/zh-HK/news/277067602.md)
*2026-02-26T15:26:56.000Z*
> CCHT's stock price has risen against the trend despite a significant decline in performance. On February 25, CCHT's stoc